This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on X or LinkedIn  

OXBA Shortlisted Finalists Announced

OXBA Shortlisted Finalists Announced

03 May 2023

Judging for the 2023 Oxfordshire Business Awards is complete, and a shortlist of 32 businesses from across Oxfordshire can now be announced. Finalists have been announced across the 12 Award categories, including Purposeful Business, Marketing Excellence, New, Small and Large Business. All of the finalists will be in for the chance of winning the overall Business of the Year Award which this year, is sponsored by Thomas Franks. Since the... Read more

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

03 May 2023

— Renowned thought leader in computational biology and data science for cancer research — — Over 180 publications on the evolutionary dynamics of cancer initiation, progression, response to therapy and emergence of resistance — OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors. Prof. Michor is a professor of Computational Biology... Read more

TOSP is delighted to be supporting BioTrinity again! See us on stand 10.

TOSP is delighted to be supporting BioTrinity again! See us on stand 10.

14 Apr 2023

BioTrinity is a great conference to hear about the latest developments in life sciences and make new contacts. We'll be at stand 10, talking about our pipeline of new state-of-the art lab and office buildings, perfect grow-on space for innovative companies. Details here.  Read more

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics

14 Apr 2023

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics Fri 14th April 2023 Oxford Nanopore Technologies and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics... Read more

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

03 Apr 2023

New Jersey, USA, and Oxford, UK: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a focus on the treatment and diagnosis of cancer, and Orbit Discovery Ltd (Orbit), a leader in the discovery of therapeutic peptide hits, announced today that they have entered into a collaboration to identify specific cell targeting peptides and advance the development of novel radiopharmaceuticals. The agreement covers... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More